1. Home
  2. HAIN vs XGN Comparison

HAIN vs XGN Comparison

Compare HAIN & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$0.63

Market Cap

70.2M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$4.67

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAIN
XGN
Founded
1993
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.2M
71.2M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
HAIN
XGN
Price
$0.63
$4.67
Analyst Decision
Hold
Strong Buy
Analyst Count
9
7
Target Price
$2.23
$8.86
AVG Volume (30 Days)
720.1K
401.9K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,457,769,000.00
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$2.59
52 Week High
$1.95
$12.23

Technical Indicators

Market Signals
Indicator
HAIN
XGN
Relative Strength Index (RSI) 35.89 57.89
Support Level $0.58 $2.68
Resistance Level $0.73 $5.55
Average True Range (ATR) 0.06 0.42
MACD -0.02 -0.07
Stochastic Oscillator 2.19 36.81

Price Performance

Historical Comparison
HAIN
XGN

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: